GMCB Oversight of Drug Prices (S.98) - May 1, 2024
On Tuesday, Nolan Langweil (Principal Fiscal Analyst, Joint Fiscal Office) reviewed S.98 with the House Appropriations Committee. The bill relates to Green Mountain Care Board (GMCB) authority over prescription drug costs. The House Health Care Committee had made amendments concerning the GMCB Nominating Committee, and then passed the bill on to this Committee.
Read moreGMCB Oversight of Drug Prices (S.98) - March 15, 2024
Jennifer Carbee (Director, Office of Legislative Counsel) reviewed amendments on S.98 on Friday. It is an act relating to Green Mountain Care Board (GMCB) authority over prescription drug costs. It specifies that the GMCB, in consultation with its own technical advisory groups and other state agencies, shall explore and create a framework and methodology for implementing a program to oversee the cost of prescription drugs for Vermont consumers and Vermont’s health care system. The Board shall consider options for and likely impacts of regulating the cost of prescription drugs that includes prescription drug affordability.
Read moreGMCB Oversight of Drug Prices (S.98) - Feb 8, 2024
Charles Becker (Staff Attorney, Office of Health Care Advocate (HCA)) testified before the Senate Health & Welfare Committee on Thursday morning about S.98, an act relating to GMCB authority over prescription drug costs. He specifically addressed Copay Accumulator Adjustment Programs, considering them to be a problem in need of a solution. He believes at least part of the problem is that we have a system based on hidden discounts and rebates that incentivizes high drug list prices.
Read moreGMCB Oversight of Drug Prices (S.98) - Feb 2, 2024
Susan Barrett (Executive Director, Green Mountain Care Board (GMCB)) and Julia Boles (Health Policy Advisor, GMCB) opened the Friday session with Senate Health & Welfare Committee discussing the GMCB. Their mission is to drive system-wide improvements in access, affordability and quality of health care to improve the health of Vermonters. They regulate major areas of Vermont’s health care system in service of the public interest. They also serve as an unbiased source of information and analysis on health system performance. Thirdly, they monitor and evaluate health care payment and delivery system reform to provide public care payment delivery system reform to provide public transparency.
Read more